Your browser doesn't support javascript.
loading
Corrigendum to 'IDH1 and IDH2 mutations in patients with acute myeloid leukemia: Suitable targets for minimal residual disease monitoring?' Clinical Biochemistry 61 (2018) 34-39.
Petrova, Lucie; Vrbacky, Filip; Lanska, Miriam; Zavrelova, Alzbeta; Zak, Pavel; Hrochova, Katerina.
Afiliação
  • Petrova L; Institute of Clinical Biochemistry and Diagnostics, University Hospital Hradec Králové, Hradec Králové, Czech Republic. Electronic address: lucie.petrova@fnhk.cz.
  • Vrbacky F; 4th Department of Internal Medicine - Haematology, University Hospital Hradec Králové and Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic.
  • Lanska M; 4th Department of Internal Medicine - Haematology, University Hospital Hradec Králové and Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic.
  • Zavrelova A; 4th Department of Internal Medicine - Haematology, University Hospital Hradec Králové and Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic.
  • Zak P; 4th Department of Internal Medicine - Haematology, University Hospital Hradec Králové and Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic.
  • Hrochova K; Institute of Clinical Biochemistry and Diagnostics, University Hospital Hradec Králové, Hradec Králové, Czech Republic.
Clin Biochem ; 63: 161, 2019 01.
Article em En | MEDLINE | ID: mdl-30340751
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2019 Tipo de documento: Article